Elsa Irving is a Senior Research Scientist at AstraZeneca, where they focus on advancing cancer treatment strategies. Previously, they completed a PhD in paediatric oncology at UCL, examining the role of protein tyrosine phosphatases in neuroblastoma. Elsa has a background in resistance to PARP inhibitors and has utilized innovative techniques such as RNAi and CRISPR in their research. They earned a Bachelor's Degree in Biochemistry from The University of Manchester, graduating with first-class honors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices